| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human ITPKC recombinant protein (Position: D292-E607) was used as the immunogen for the ITPKC antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
ITPKC Antibody / Inositol-trisphosphate 3-kinase C is a anti-ITPKC Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as ELISA, Flow cytometry (FACS), Western blot (WB) with listed reactivity in Human.
Key elements and design rationale
- Target: ITPKC
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): ELISA, FACS, WB
Biological background
ITPKC is encoded by the ITPKC gene located on human chromosome 19q13.2. The protein is approximately 461 amino acids long and localizes to the cytoplasm, where it modulates calcium flux by regulating IP3 metabolism. Through phosphorylation of IP3, ITPKC reduces calcium release from the endoplasmic reticulum, thereby attenuating NFAT activation and T-cell proliferation.
The ITPKC antibody detects a 52 kilodalton band by western blot and exhibits diffuse cytoplasmic staining under fluorescence microscopy. ITPKC plays a pivotal role in immune regulation, particularly in T-cell receptor signaling. Genetic variants of ITPKC are associated with Kawasaki disease, an inflammatory vascular disorder, due to dysregulated calcium-dependent immune activation.
Beyond immunity, ITPKC influences endothelial barrier function and smooth muscle contraction, linking it to cardiovascular homeostasis. It also interacts with other kinases and phosphatases in the phosphoinositide signaling pathway, integrating metabolic and signaling cues. In cancer cells, ITPKC expression affects proliferation and angiogenesis by controlling intracellular calcium oscillations.
Because of its dual role in immune and vascular signaling, ITPKC is a key enzyme at the crossroads of inflammation and calcium dynamics.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
